Carbamazepine in Severe Liver Disease Due to Alpha-1 Antitrypsin Deficiency
A Preliminary Study of the Efficacy and Safety of Carbamazepine in Severe Liver Disease Due to Alpha-1 Antitrypsin Deficiency A Preliminary Study of the Efficacy and Safety of Carbamazepinein Severe Liver Disease Due to Alpha- ...
Novartis;National Institutes of Health (NIH);National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK);University of Pittsburgh Novartis;National Institutes of Health (NIH);National Institute of Diabetes and Digestive and Kidney ...